Short Communication:HIV Type 1 Variants with Nevirapine Resistance Mutations Are Rarely Detected in Antiretroviral Drug-Naive African Women with Subtypes A, C, and D-Reference-Cited by-同舟云学术

Short Communication:HIV Type 1 Variants with Nevirapine Resistance Mutations Are Rarely Detected in Antiretroviral Drug-Naive African Women with Subtypes A, C, and D

Published:2007-06 Issue:6 Volume:23 Page:764-768
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Church Jessica D.¹,Hudelson Sarah E.¹,Guay Laura A.¹,Chen Shu²,Hoover Donald R.³,Parkin Neil⁴,Fiscus Susan A.⁵,Mmiro Francis⁶,Musoke Philippa⁷,Kumwenda Newton²,Jackson J. Brooks¹,Taha Taha E.²,Eshleman Susan H.¹

Affiliation:

1. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

2. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205.

3. Department of Statistics and Institute for Health, Health Care Policy and Aging Research, Rutgers University, Piscataway, New Jersey 08854.

4. Monogram Biosciences, South San Francisco, California 94080.

5. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.

6. Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda.

7. Department of Paediatrics, Makerere University, Kampala, Uganda.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2006.0272

Reference15 articles.

1. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

2. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

3. Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African Setting

4. Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVP

5. Sensitive Drug‐Resistance Assays Reveal Long‐Term Persistence of HIV‐1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single‐Dose NVP: HIVNET 012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Clinically Significant Drug-Resistance Mutations in HIV-1 Subtype C–Infected Women After Discontinuation of NRTI-Based or PI-Based HAART for PMTCT in Botswana;JAIDS Journal of Acquired Immune Deficiency Syndromes;2013-08-15

2. Antibody Maturation and Viral Diversification in HIV-Infected Women;PLoS ONE;2013-02-27

3. Historical Perspective of African-Based Research on HIV-1 Transmission Through Breastfeeding: The Malawi Experience;Advances in Experimental Medicine and Biology;2012

4. HIV vaccines: current status worldwide and in Africa;AIDS;2010-10

5. Transmitted drug resistance in nonsubtype B HIV-1 infection;HIV Therapy;2009-09